Transformer-based multi-omics synthesis for early risk stratification and preventive surveillance in liver oncology.

10

Background: The efficacy of early intervention in liver oncology is frequently compromised by the profound molecular heterogeneity of hepatocellular carcinoma (HCC) and its complex immune microenvironment. Conventional diagnostic modalities often fail to detect the subtle genomic and metabolic transitions that precede malignant transformation, resulting in delayed clinical responses. This study investigates a proprietary Machine Learning (ML) framework designed to integrate high-dimensional multi-omics data with longitudinal clinical parameters. The goal is to bridge existing diagnostic voids and facilitate proactive, preventive surveillance for high-risk cohorts. Methods: Utilizing a transformer-based multi-task deep learning architecture, we evaluated a comprehensive dataset from 2,200 participants (aged 5–16 years for pediatric variants/adult cohorts). The framework integrated transcriptomic (scRNA-seq), epigenomic (ATAC-seq), and genomic markers through three specialized computational modules: Genomic Feature Discovery: Leveraged deep learning algorithms for the automated identification of salient mutations and cellular signatures. Predictive Homeostatic Modeling: Employed Graph Attention Networks (GAT) to map temporal cellular stability and isolate subclinical shifts in hepatic function. Preventive Risk Stratification: Synthesized patient demographics, etiology, and metabolic profiles to generate individualized risk scores for precision screening. Results: The ML-driven framework demonstrated superior diagnostic accuracy, yielding an AUC-ROC of 0.84–0.93 with a 93.9% sensitivity for identifying early-stage intervention candidates. Multi-omics synthesis improved the predictive accuracy of disease recurrence or progression by 23.4%–24.8% compared to traditional biomarkers ($P < 0.002$). Notably, the model isolated distinct cellular subpopulations associated with chronic cellular stress and immune exhaustion, providing high-fidelity biological triggers for preventive management. In underserved demographics, the system successfully detected subclinical declines and identified specific socio-behavioral impediments to screening adherence. Conclusions: This research marks a significant shift in liver oncology by merging rigorous genomic characterization with real-time predictive analytics. By enabling "humanized" digital surveillance, the system effectively reconciles static diagnostic snapshots with the dynamic progression of liver disease. These precision-driven public health strategies prioritize early-stage prevention and targeted clinical intervention, ultimately optimizing survival outcomes and mitigating the global burden of advanced liver malignancies.